Cargando…
Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
BACKGROUND: Bacteremia by Pseudomonas aeruginosa represents one severe infection. It is not clear whether beta-lactam monotherapy leads to similar rates of treatment success compared to combinations of beta-lactams with aminoglycosides or quinolones. METHODS: Retrospective cohort study from 3 tertia...
Autores principales: | Bliziotis, Ioannis A., Petrosillo, Nicola, Michalopoulos, Argyris, Samonis, George, Falagas, Matthew E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202542/ https://www.ncbi.nlm.nih.gov/pubmed/22046290 http://dx.doi.org/10.1371/journal.pone.0026470 |
Ejemplares similares
-
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
por: Falagas, Matthew E, et al.
Publicado: (2005) -
Worldwide research productivity in critical care medicine
por: Michalopoulos, Argyris, et al.
Publicado: (2005) -
In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia
por: Spottiswoode, Natasha, et al.
Publicado: (2023) -
Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials
por: Falagas, Matthew E, et al.
Publicado: (2006) -
Beta-lactam, aminoglycoside, and quinolone resistance in Escherichia coli strains isolated from shrimps and mussels in the Marmara Sea
por: Celik, Baran, et al.
Publicado: (2023)